JACKSON PURCHASE MEDICAL CENTER — History
CCN 180116 | 3-year financial timeline | COVID resilience: 44/100
🛡️ Public data only — no PHI permitted on this instance.
$91M
Latest Revenue (FY2022)
+4.1%
Revenue CAGR (3yr)
-6.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $84M | $115M | $91M | -21.0% | +4.1% |
| Operating Expenses | $84M | $99M | $97M | -1.7% | +7.7% |
| Operating Margin | 0.2% | 14.2% | -6.8% | -147.7% | +0.0% |
| Net Income | $0M | $16M | $-6M | -137.7% | +0.0% |
| Licensed Beds | 95 | 95 | 95 | +0.0% | +0.0% |
| Total Patient Days | 17,749 | 19,577 | 15,926 | -18.6% | -5.3% |
| Medicare Day % | 41% | 34% | 32% | -6.4% | -12.1% |
| Medicaid Day % | 3% | 2% | 2% | +37.3% | -12.1% |
COVID Impact & Recovery
Resilience Score: 44/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.4% ($84M → $91M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.1%
This Hospital
+7.6%
State Avg
Latest Margin
-6.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $95M | -10.2% |
| FY2024 (proj) | $98M | -13.7% |
| FY2025 (proj) | $102M | -17.2% |